Nektar Therapeutics (NKTR)
1.57
-0.10
(-5.99%)
USD |
NASDAQ |
May 03, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Cash from Operations (TTM): -192.61M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -192.61M |
| September 30, 2023 | -203.26M |
| June 30, 2023 | -244.03M |
| March 31, 2023 | -267.50M |
| December 31, 2022 | -304.01M |
| September 30, 2022 | -397.84M |
| June 30, 2022 | -416.09M |
| March 31, 2022 | -424.00M |
| December 31, 2021 | -412.66M |
| September 30, 2021 | -359.76M |
| June 30, 2021 | -311.30M |
| March 31, 2021 | -312.30M |
| December 31, 2020 | -313.29M |
| September 30, 2020 | -339.88M |
| June 30, 2020 | -355.84M |
| March 31, 2020 | -325.86M |
| December 31, 2019 | -328.68M |
| September 30, 2019 | -321.01M |
| June 30, 2019 | -323.78M |
| March 31, 2019 | 689.78M |
| December 31, 2018 | 718.21M |
| September 30, 2018 | 755.36M |
| June 30, 2018 | 919.85M |
| March 31, 2018 | -98.31M |
| December 31, 2017 | -80.41M |
| Date | Value |
|---|---|
| September 30, 2017 | -52.42M |
| June 30, 2017 | -172.86M |
| March 31, 2017 | -127.94M |
| December 31, 2016 | -117.02M |
| September 30, 2016 | -139.72M |
| June 30, 2016 | -126.39M |
| March 31, 2016 | -160.04M |
| December 31, 2015 | -73.08M |
| September 30, 2015 | -22.60M |
| June 30, 2015 | -54.57M |
| March 31, 2015 | -16.40M |
| December 31, 2014 | -142.01M |
| September 30, 2014 | -63.75M |
| June 30, 2014 | -37.45M |
| March 31, 2014 | -62.71M |
| December 31, 2013 | -38.53M |
| September 30, 2013 | -139.53M |
| June 30, 2013 | -147.00M |
| March 31, 2013 | -133.25M |
| December 31, 2012 | -129.76M |
| September 30, 2012 | -124.59M |
| June 30, 2012 | -119.29M |
| March 31, 2012 | -133.49M |
| December 31, 2011 | -113.74M |
| September 30, 2011 | -51.12M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-424.00M
Minimum
Mar 2022
-192.61M
Maximum
Dec 2023
-323.88M
Average
-323.78M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| Stereotaxis Inc | -9.139M |
| Vanda Pharmaceuticals Inc | 12.80M |
| Cara Therapeutics Inc | -92.08M |
| Avid Bioservices Inc | 12.68M |
| Rigel Pharmaceuticals Inc | -5.743M |